0.266
5.07%
-0.0142
After Hours:
.2602
-0.0058
-2.18%
iSpecimen Inc stock is currently priced at $0.266, with a 24-hour trading volume of 183.47K.
It has seen a -5.07% decreased in the last 24 hours and a +12.47% rose in the past month.
The chart indicates a potential bearish trend, as the stock is below the $0.2842 pivot point. If it approaches the $0.2561 support level, significant changes may occur.
Previous Close:
$0.2802
Open:
$0.2802
24h Volume:
183.47K
Market Cap:
$2.42M
Revenue:
$9.93M
Net Income/Loss:
$-11.10M
P/E Ratio:
-0.2128
EPS:
-1.25
Net Cash Flow:
$-10.55M
1W Performance:
-7.73%
1M Performance:
+12.47%
6M Performance:
-55.67%
1Y Performance:
-81.59%
iSpecimen Inc Stock (ISPC) Company Profile
Name
iSpecimen Inc
Sector
Industry
Phone
781 301 6700
Address
450 Bedford Street, Lexington
iSpecimen Inc Stock (ISPC) Latest News
iSpecimen Reschedules Full Year 2023 Earnings Release and Conference Call
GlobeNewswire Inc.
iSpecimen to Report Full Year 2023 Financial Results on March 13, 2024
GlobeNewswire Inc.
iSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based Research
GlobeNewswire Inc.
iSpecimen to Participate in Maxim Group Healthcare IT Virtual Conference, January 24 & 25, 2024
GlobeNewswire Inc.
iSpecimen Strengthens Global Oncology Biospecimen Offering
GlobeNewswire Inc.
iSpecimen Reports Third Quarter 2023 Financial and Operating Results
GlobeNewswire Inc.
iSpecimen Inc Stock (ISPC) Financials Data
iSpecimen Inc (ISPC) Revenue 2024
ISPC reported a revenue (TTM) of $9.93 million for the quarter ending December 31, 2023, a -4.56% decline year-over-year.
iSpecimen Inc (ISPC) Net Income 2024
ISPC net income (TTM) was -$11.10 million for the quarter ending December 31, 2023, a -8.33% decrease year-over-year.
iSpecimen Inc (ISPC) Cash Flow 2024
ISPC recorded a free cash flow (TTM) of -$10.55 million for the quarter ending December 31, 2023, a -17.13% decrease year-over-year.
iSpecimen Inc (ISPC) Earnings per Share 2024
ISPC earnings per share (TTM) was -$1.23 for the quarter ending December 31, 2023, a -6.03% decline year-over-year.
About iSpecimen Inc
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.
Cap:
|
Volume (24h):